Maynard Um
-
-
-
-
-
-
-
Indaptus Therapeutics (INDP) Files $100M Mixed Shelf
-
-
-
-
-
-
-
Indaptus Therapeutics (INDP) expands Patent Portfolio in China, Japan, and Israel
-
-
-
-
-
-
-
Indaptus Therapeutics (INDP) Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20
-
-
-
-
418,485 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

